James Crowe

James Crowe

Vanderbilt University

H-index: 99

North America-United States

About James Crowe

James Crowe, With an exceptional h-index of 99 and a recent h-index of 64 (since 2020), a distinguished researcher at Vanderbilt University, specializes in the field of Immunology, Virology, Vaccines, Antibodies.

His recent articles reflect a diverse array of research interests and contributions to the field:

Pan-ebola virus neutralizing human antibodies and methods of use therefor

Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity

Functional and antigenic landscape of the Nipah virus receptor binding protein

Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody (preprint)

Human Japanese Encephalitis Virus antibodies and methods of use therefor

Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting

Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates

James Crowe Information

University

Position

Vanderbilt University Medical Center

Citations(all)

35019

Citations(since 2020)

19046

Cited By

21836

hIndex(all)

99

hIndex(since 2020)

64

i10Index(all)

364

i10Index(since 2020)

283

Email

University Profile Page

Vanderbilt University

Google Scholar

View Google Scholar Profile

James Crowe Skills & Research Interests

Immunology

Virology

Vaccines

Antibodies

Top articles of James Crowe

Title

Journal

Author(s)

Publication Date

Pan-ebola virus neutralizing human antibodies and methods of use therefor

2024/3/26

Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity

The Journal of Immunology

Alexandra A Abu-Shmais

Rose J Miller

Alexis K Janke

Rachael M Wolters

Clinton M Holt

...

2024/5/1

Functional and antigenic landscape of the Nipah virus receptor binding protein

bioRxiv

Brendan B Larsen

Teagan McMahon

Jack T Brown

Zhaoqian Wang

Caelan E Radford

...

2024

Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

2023/5/30

Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody (preprint)

Nicole V Johnson

Steven Wall

Kevin Kramer

Clinton Holt

Sivakumar Periasamy

...

2024

Human Japanese Encephalitis Virus antibodies and methods of use therefor

2024/4/16

Prototype mRNA vaccines imprint broadly neutralizing human serum antibodies after Omicron variant-matched boosting

bioRxiv

Chieh-Yu Liang

Saravanan Raju

Zhuoming Liu

Yuhao Li

Guha A Arunkumar

...

2024

Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates

Science Translational Medicine

Larry Zeitlin

Robert W Cross

Courtney Woolsey

Brandyn R West

Viktoriya Borisevich

...

2024/4/3

Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses.

Alexander Bukreyev

Michelle Meyer

Bronwyn Gunn

Colette Pietzsch

Chandru Subramani

...

2024/3/26

Potently neutralizing human mAbs against the zoonotic pararubulavirus Sosuga virus

JCI insight

Helen M Parrington

Nurgun Kose

Erica Armstrong

Laura Handal

Summer Diaz

...

2023/4/4

Development of a kinetic ELISA and reactive B cell frequency assay to detect respiratory syncytial virus pre-fusion F protein-specific immune responses in infants

Journal of the Pediatric Infectious Diseases Society

Stephanie L Rolsma

Sandra M Yoder

Rachel S Nargi

Eric Brady

Nurgun Kose

...

2023/5/1

Mechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody

Nature Microbiology

Robert Stass

Taylor B Engdahl

Nathaniel S Chapman

Rachael M Wolters

Laura S Handal

...

2023/7

Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses

Nature Communications

Nathaniel S Chapman

Ruben JG Hulswit

Jonna LB Westover

Robert Stass

Guido C Paesen

...

2023/9/13

A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection

Cell Reports Medicine

Lucas J Adams

Laura A VanBlargan

Zhuoming Liu

Pavlo Gilchuk

Haiyan Zhao

...

2023/12/19

Cross-reactive coronavirus antibodies and uses thereof

2023/11/2

Corrigendum to: Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants

Journal of the Pediatric Infectious Diseases Society

Sandra M Yoder Rolsma

Rachel S Nargi

Eric Brady

Nurgun Kose

Natalia Jimenez-Truque

...

2023

Human antibodies that neutralize zika virus and methods of use therefor

2023/3/16

Human antibodies to alphaviruses

2023/3/2

Structural constraints link differences in neutralization potency of human anti-Eastern equine encephalitis virus monoclonal antibodies

Proceedings of the National Academy of Sciences

Lauren E Williamson

Abhishek Bandyopadhyay

Kevin Bailey

Devika Sirohi

Thomas Klose

...

2023/3/28

Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus

Frontiers in immunology

Nicole E Skinner

Clinton O Ogega

Nicole Frumento

Kaitlyn E Clark

Harry Paul

...

2023/4/25

See List of Professors in James Crowe University(Vanderbilt University)

Co-Authors

H-index: 105
Eva HARRIS

Eva HARRIS

University of California, Berkeley

H-index: 91
Daved H. Fremont

Daved H. Fremont

Washington University in St. Louis

H-index: 84
Christopher F. Basler

Christopher F. Basler

Georgia State University

H-index: 65
John V Williams

John V Williams

University of Pittsburgh

H-index: 53
Bryan E. Shepherd

Bryan E. Shepherd

Vanderbilt University

H-index: 50
James C Slaughter

James C Slaughter

Vanderbilt University

academic-engine